IMPURITIES AVAILABLE FOR 'Idasanutlin'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Idasanutlin. Idasanutlin is a small-molecule MDM2 inhibitor developed as an anticancer agent targeting the p53 tumor suppressor pathway. It works by blocking the interaction between MDM2 and p53, thereby preventing p53 degradation and restoring its tumor-suppressive functions such as cell cycle arrest and apoptosis. Idasanutlin has shown promise in the treatment of acute myeloid leukemia (AML) and other malignancies characterized by wild-type p53 expression. It is administered orally and exhibits selective, high-affinity binding to MDM2. The drug enhances the sensitivity of cancer cells to apoptosis without affecting normal cells significantly. Common side effects include nausea, diarrhea, thrombocytopenia, and fatigue. Although clinical development faced challenges, idasanutlin remains a key compound in the study of MDM2–p53 targeted cancer therapy. Buy high quality Idasanutlin from Omsynth Lifesciences.